Research Scientist for Solid Dosage Forms
Novo Nordisk A/S-Copenhagen, HOVE
This is your chance to join the world leader in diabetes care and put your personal mark on R&D projects with the powerful potential to lift the quality of life for millions of people around the world. With the creation of the Oral Protein Formulation Unit (OPF), Novo Nordisk is starting its voyage towards the development of Solid Dosage Forms of diabetes proteins for oral delivery. Our ambition is to develop break-through products with orally available versions of insulin and GLP-1. You will be involved in CMC activities from early research to phase 2 clinical trials within protein formula...